Delivery Order SPE2DB24D1104-SPE2DB24FYAA4

Award Date 7/3/24
Potential Completion Date 7/5/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of M-M-R II vaccine vials to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order with a firm fixed price of $2,049.52 and an ultimate completion date of July 31, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
The U.S. government agency, the Defense Logistics Agency (DLA), awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The $2,184.03 fixed-price contract is for the supply of M-M-R II vaccine vials. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities to support military treatment programs...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of M-M-R II vaccine vials. The contract has a ceiling value of $1,024.76 and a completion date of April 17, 2024. This delivery order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a total potential value of up to $999,999,999.00 through December 31, 2025. The IDC enables...
The federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $3,757.74. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is March 20, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency within the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company, for a ceiling value of $1,248.84. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is February 1, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract has a firm fixed price of $2,175.98 and a completion date of June 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of M-M-R II vaccine vials. The contract has a total ceiling value of $1,113.35 and runs through March 3, 2025. The contract is a Delivery Order placed under an existing Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and expiring in November 2026. This IDC serves as a primary vehicle...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $22,155.60 and is a firm fixed-price delivery order with a completion date of March 11, 2025. It is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $1,537.14, is for the delivery of M-M-R II vaccine vials. This is a firm fixed-price delivery order contract with a completion date of May 21, 2024. The contract does not have a set-aside designation. Additionally, Amerisourcebergen Drug Corp holds a larger Indefinite...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on April 18, 2024. The contract has a ceiling value of $7,685.70 and is a firm fixed-price delivery order with an ultimate completion date of April 19, 2024. There is no set-aside designation for this...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB24FYAA4
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of M-M-R II vaccine vials to the government. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for a firm fixed price of $1,024.76. The contract has a completion date of July 5, 2024 and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical that runs through December 31, 2025. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 10/2/24, 9:44 AM